mong term infants, hypoxicischemic encephalopathy due to acute perinatal asphyxia remains an important cause of neurodevelopmental deficits in childhood. Infants with moderate encephalopathy have a 10 percent risk of death, and those who survive have a 30 percent risk of disabilities. Sixty percent of infants with severe encephalopathy die, and many, if not all, survivors are handicapped. 1, 2 Treatment is currently limited to supportive intensive care.
Reductions in brain temperature by 2°C to 5°C provide neuroprotection in newborn and adult animal models of brain ischemia. [3] [4] [5] [6] [7] [8] [9] [10] Brain cooling has a favorable effect on multiple pathways contributing to brain injury, including excitatory amino acids, 11 the cerebral energy state, 12 cerebral blood flow and metabolism, 13 nitric oxide production, 11 and apoptosis. 14 Brain cooling is effective in reducing the extent of brain injury even when it is initiated up to 5.5 hours after brain ischemia in near-term sheep fetuses. 10 We have previously demonstrated the feasibility of whole-body cooling in a pilot study of neonates with hypoxic-ischemic encephalopathy. 15 Therefore, we conducted a randomized, controlled trial to evaluate whether whole-body cooling initiated before 6 hours of age and continued for 72 hours in term infants with encephalopathy would reduce death or disability at 18 to 22 months of age as compared with infants given usual care.
A committee of the principal investigators from participating sites developed a manual of operations that specified neurologic criteria for eligibility and details of the cooling and rewarming procedure. Each principal investigator certified additional neonatologists to perform the neurologic examination, and a training session for research personnel was held to standardize all study procedures. The protocol was approved by the institutional review board at each site.
screening
Infants were screened for eligibility if they had a gestational age of at least 36 weeks and were admitted to the neonatal intensive care unit at six hours of age or less with either poor respiratory effort at birth and a need for resuscitation or a diagnosis of encephalopathy.
inclusion criteria
Infants were evaluated according to physiological criteria and subsequently by a neurologic examination. 15 Eligibility criteria included a pH of 7.0 or less or a base deficit of 16 mmol per liter or more in a sample of umbilical-cord blood or any blood during the first hour after birth. If, during this interval, a pH was between 7.01 and 7.15, a base deficit was between 10 and 15.9 mmol per liter, or a blood gas was not available, additional criteria were required. These included an acute perinatal event (e.g., late or variable decelerations, cord prolapse, cord rupture, uterine rupture, maternal trauma, hemorrhage, or cardiorespiratory arrest) and either a 10-minute Apgar score of 5 or less or assisted ventilation initiated at birth and continued for at least 10 minutes.
Once these criteria were met, all infants underwent a standardized neurologic examination performed by a certified examiner. Infants were candidates for the study when encephalopathy or seizures were present. Encephalopathy was defined as the presence of one or more signs in at least three of the following six categories (Table 1) : level of consciousness, spontaneous activity, posture, tone, primitive reflexes (suck or Moro), and autonomic nervous system (pupils, heart rate, or respiration). The number of moderate or severe signs determined the extent of encephalopathy; if signs were equally distributed, the designation was based on the level of consciousness. Exclusion criteria were a methods an inability to enroll by six hours of age, a major congenital abnormality, a severe growth restriction (birth weight of ≤1800 g), and refusal of consent by a parent or an attending neonatologist; moribund infants for whom no further aggressive treatment was planned also were excluded.
treatment assignment
Written informed consent was obtained from the parents of 208 of 239 eligible infants. Consent was not requested from 16 mothers, parents refused consent for 10 infants, and physicians opposed the enrollment of 5 infants. After informed consent was obtained from a parent, the assignment to a treatment group was performed randomly by telephone by the data-coordinating center (RTI International). Assignments were stratified according to center and were generated by a random, permutedblock algorithm with block sizes of two and four. Infants in the hypothermia group were placed on an infant-size blanket, 25 in. by 33 in. (64 cm by 84 cm), that was precooled to 5°C (Blanketrol II Hyper-Hypothermia System, Cincinnati Sub-Zero). Blankets and cooling systems were purchased by each site. An esophageal probe was inserted, and the esophageal temperature was lowered to 33.5°C by the blanket's servomechanism. A second blanket, 25 in. by 64 in. (64 cm by 163 cm), was attached to the cooling system. Water circulated simultaneously through both blankets to diminish the variability in the esophageal temperature. 15 Neither an overhead warmer nor any other heat source was used during the cooling period. Abdominal-wall skin temperature was monitored with a skin probe by means of either the radiant warmer (with the heater turned off ) or the temperature-monitoring unit (Mon-a-therm, Mallinckrodt Medical). Esophageal and skin temperatures were monitored continuously and recorded every 15 minutes for the first 4 hours, every hour for the next 8 hours, and every 4 hours during the remaining period of cooling. After 72 hours of hypothermia, the set point of the automatic control on the cooling system was increased by 0.5°C per hour. After six hours, the esophageal probe was removed, and skin temperature was controlled by the radiant warmer's servomechanism. The temperature of the warmer was set 0.5°C higher than the skin temperature and was increased 0.5°C every hour until the set point of the warmer reached 36.5°C. Infants received routine clinical care, including the monitoring of vital signs and surveillance for organ dysfunction. Blood-gas measurements in the hypothermia group were corrected for body temperature.
Infants in the control group were cared for on overhead radiant warmers with abdominal-wall skin and esophageal temperatures recorded every four hours. Skin temperature was maintained by the servomechanism between 36.5°C and 37.0°C initially, and subsequent adjustments were made according to usual care at each center. Infants in the control group received the same monitoring of vital signs and surveillance for organ dysfunction as did the infants in the hypothermia group.
adverse events
During the 72-hour intervention period, infants in both groups were monitored for cardiac arrhythmia, persistent acidosis, major-vessel thrombosis or * Plus-minus values are means ±SD. Percentages are based on the number of mothers or infants for whom data were available. Because of rounding, not all percentages sum to 100. † Race was determined by interviewing the mothers. ‡ Seventy infants (39 in the hypothermia group and 31 in the control group) had more than one intrapartum complication at birth. Intrapartum complications included antepartum hemorrhage (placenta previa, placental abruption, or threatened abortion resulting in bleeding that was external [vaginal bleeding] or occult [retroplacental clot] after 20 weeks of gestation); maternal hemorrhage (acute bleeding at delivery from placenta previa or placental abruption); and maternal pyrexia (temperature ≥37.6°C). § Data are for this characteristic at the time of randomization. One infant in the hypothermia group qualified with seizures but was missing a neurologic examination to permit classification of the extent of encephalopathy. The new england journal of medicine bleeding, skin changes, and death. Any equipment malfunction also was noted. All adverse events were reported within 72 hours to the institutional review board at the site and to the data center.
follow-up
The primary outcome was death or disability (moderate or severe). All surviving infants were evaluated at 18 to 22 months of age; the families of those who did not return for follow-up were contacted by telephone to obtain information about the primary outcome. Data on growth, vision, and audiometric characteristics were obtained, and neurologic and developmental testing were performed by trained examiners who were blinded to intervention status. An assessment of neuromotor disability was based on the presence of cerebral palsy, and functional disability was graded according to the Gross Motor Function Classification System (GMFCS) 16 (Table 2) . Cooling was initiated in the hypothermia group at a median of 35.5 minutes after randomization and at an average of 302 minutes after birth.
monitoring of infants
The mean esophageal temperature at baseline was 36.6±1.0°C among the infants in the hypothermia group (Fig. 1A) . After an initial overshoot to a mean of 32.7°C, the target temperature of 33.5°C was achieved within 90 minutes and remained constant throughout the intervention period (mean, 33.4±0.9°C; 25th and 75th percentiles, 33.2°C and 33.5°C). In the control group, the mean esophageal temperature was 37.2±0.6°C during the same interval (25th and 75th percentiles, 36.9°C and 37.5°C). Esophageal temperatures in the control group exceeded 38°C on at least one measurement in 41 infants. The mean skin temperature was 31.9±1.4°C in the hypothermia group and 36.5± 0.8°C in the control group during the intervention period (Fig. 1B) . The mean heart rate was similar in the two groups before the intervention. It decreased in the hypothermia group during cooling to a mean of 109 beats per minute but remained greater than 140 beats per minute in the control group (Fig. 1C) . Blood pressure was similar in the two groups (data not shown). Table 4 ). The protective effect of hypothermia persisted after adjustment according to center and the severity of encephalopathy at randomization (relative risk, 0.76; 95 percent confidence interval, 0.60 to 0.97). A test of homogeneity of risk ratios across the centers revealed no significant interaction among treatments according to center (P=0.25). There was also no significant interaction between treatment and the severity of encephalopathy at enrollment (P=0.36). Results stratified according to the initial severity of encephalopathy (moderate or severe) are shown in Table 4 . There were 24 deaths in the hypothermia group and 38 deaths in the control group (relative risk, 0.68; 95 percent confidence interval, 0.44 to 1.05) ( Table 4 ). In the hypothermia and control groups, respectively, the rates of disabling cerebral palsy were 19 and 30 percent, the rates of blindness were 7 and 14 percent, and the rates of hearing impairment requiring aids were 4 and 6 percent (the P values for all comparisons were not significant). The proportion of infants with scores of 85 or more, 70 to 84, or below 70 on either the Mental Development Index or the Psychomotor Developmental Index also did not differ significantly between the groups.
The distribution of age at death according to The new england journal of medicine treatment group is shown in Figure 2 . Support was withdrawn from 12 infants in the hypothermia group (9 during the 72-hour intervention and 3 later during hospitalization) and 27 in the control group (10 during the intervention period, 15 later during hospitalization, and 2 after the initial hospitalization). The most frequent diagnosis for which support was withdrawn was asphyxial brain injury (8 of 12 infants in the hypothermia group and 18 of 27 in the control group).
As compared with usual care, whole-body cooling to an esophageal temperature of 33.5°C initiated within the first 6 hours after birth and continued for 72 hours reduced the rate of death or moderate or severe disability in term newborns with encephalopathy in this study. Hypothermia has been widely studied as a neuroprotective strategy in newborn and adult animals after ischemia and hypoxiaischemia. In perinatal animals (sheep, rats, and piglets [7] [8] [9] [10] 18, 19 ), hypothermia has been beneficial when implemented up to 5.5 hours after brain ischemia. 10 The eligibility criteria for this trial were designed to include infants with acute hypoxic-ischemic encephalopathy as indicated by profound fetal acidemia or infants with the need for resuscitation after acute hypoxic events. The trial was also designed to select infants who had a high probability of a poor outcome (i.e., death or disability). In the control group, the incidence of death or disability was 48 percent in the subgroup of infants with moderate encephalopathy at enrollment and 85 percent in the subgroup of infants with severe encephalopathy. In this study, the classification of encephalopathy as moderate or severe during the first hours after birth predicted outcome as readily as assessments later in the first week. 1, 2 The brain can be cooled by cooling the body, cooling the head selectively, or cooling the head and body together. The majority of studies in animals have used whole-body cooling, [3] [4] [5] [6] [7] [8] [11] [12] [13] [14] 18, 19 but some have used selective head cooling. 9, 10, [20] [21] [22] [23] [24] Whole-body cooling provides homogeneous cooling to all brain structures, including peripheral and central brain regions. 25 Selective head cooling provides greater cooling to the periphery of the brain than to the central brain structures 25 ; head cooling combined with some body cooling minimizes temperature gradients across the brain and facilitates discussion * Plus-minus values are means ±SD. Percentages are based on the number of infants for whom data were available. † Cardiac arrhythmia was defined as sustained bradycardia (one infant in the hypothermia group) or ventricular tachycardia (one infant each in the hypothermia and control groups). ‡ Persistent acidosis was defined as metabolic acidosis with a pH of less than 7.15 that persisted for more than three hours after the initiation of intervention. § Bleeding was defined as overt bleeding with a platelet count of less than 40,000 per liter with abnormal results on coagulation studies. ¶ Four infants in the hypothermia group had skin changes. Erythema, sclerema (hardening of subcutaneous tissue), cyanosis, and subcutaneous fat necrosis each occurred in one infant; these changes resolved spontaneously without scarring. ¿ The hospital course was defined as the period between randomization and discharge. ** Hepatic dysfunction was defined as an aspartate aminotransferase level above 200 IU and an alanine aminotransferase level above 100 IU. † † Hypoglycemia was defined as a blood glucose level of less than 30 mg per deciliter (1.7 mmol per liter). ‡ ‡ Hypocalcemia was defined as a blood calcium level less than 8 mmol per liter. § § This variable applies to surviving infants only; 83 infants in the hypothermia group and 77 in the control group survived to initial hospital discharge. the cooling of central regions. 24 Given the propensity for hypoxic-ischemic injury to affect deep-brain structures such as the thalamus, internal capsule, and basal ganglia in the human neonate, 26-28 we chose whole-body cooling to achieve a consistent reduction in brain temperature in such structures. The target temperature of 33.5°C was selected on the basis of studies in animals 3 that showed attenuation of brain injury at this temperature without the adverse effects (e.g., myocardial injury) that occur at lower temperatures. 29 The cooling system used in this study was easily initiated, achieved the target temperature rapidly, and required minimal effort by providers to monitor the temperature. These features are important, given that the intervention was initiated within a defined time interval and maintained for 72 hours. Cooling was well tolerated and not associated with an increase in death or serious adverse events. If esophageal temperature is a proxy for the core temperature of the brain, the observation that more than one third of the infants in the control group had an elevated esophageal temperature on at least one occasion suggests that brain temperatures may * Percentages are based on the number of infants for whom data were available.
† Relative risks shown are adjusted according to center. CI denotes confidence interval. ‡ Data were unobtainable for three patients in the control group. Severe disability was defined as any of the following: Mental Development Index score below 70, Gross Motor Function Classification System (GMFCS) grade level 3 to 5, hearing impairment requiring hearing aids, or blindness. Moderate disability was defined as a Mental Development Index score of 70 to 84 and one or more of the following: GMFCS grade of level 2, hearing impairment with no amplification, or a persistent seizure disorder. § Sixty-nine infants in the hypothermia group and 63 in the control group had moderate encephalopathy, and 32 infants in the hypothermia group and 40 in the control group had severe encephalopathy. ¶ Data were unavailable for 3 of 78 infants who survived in the hypothermia group and 6 of 68 who survived in the control group. ¿ Data were unavailable for four infants in the hypothermia group and six in the control group. ** Data were unavailable for one infant in the hypothermia group and four in the control group. † † Data were unavailable for three infants in the hypothermia group and five in the control group. Severe hearing impairment ** 3 (4) have risen intermittently in these infants. This study cannot establish a causal relationship between an elevated esophageal temperature and brain injury. An elevated brain temperature may result from brain injury, and conversely, a moderate increase in brain temperature can exacerbate hypoxic-ischemic brain injury. 30, 31 A concern with any therapy that reduces mortality among infants at high risk of death and disability is the possibility of an increase in the number of infants who survive with disabilities. In our study, there was no evidence of increased rates of moderate or severe disability at 18 to 22 months of age among infants treated with hypothermia. The rates of disabling cerebral palsy were 19 percent in the hypothermia group and 30 percent in the control group, and the rates of a Mental Development Index below 70 were 25 percent and 39 percent, respectively.
Recently, the results of a large, randomized, controlled trial of selective head cooling with systemic hypothermia (rectal temperature, 34°C to 35°C for 72 hours) (the Cool-Cap Trial) 32 and a pilot trial of body cooling (rectal temperature, 33°C for 48 hours) 33 have been published. The Cool-Cap Trial demonstrated a benefit associated with selective head cooling among infants with moderate abnormalities on an amplitude-integrated electroencephalogram (aEEG) at enrollment, 32 whereas the pilot trial of body cooling showed protection among all infants studied. 33 The eligibility criteria in our study did not make use of the aEEG, although data are accumulating to support the possibility that aEEG results predict outcomes after perinatal hypoxiaischemia. 34, 35 The criteria we used for eligibility are assessed easily by clinicians and do not require the availability of aEEG equipment.
In summary, our findings demonstrate the safety and effectiveness of whole-body cooling in reducing the risk of death or disability among infants with moderate or severe encephalopathy. Rigorous criteria were used to define moderate and severe encephalopathy, and we used certified examiners and trained personnel to implement and monitor the study interventions and outcome.
Supported by grants from the National Institute of Child Health and Human Development and the Department of Health and Human Services (U10 HD21385, U10 HD40689, U10 HD27871, U10  HD21373, U01 HD36790, U10 HD40498, U10 HD40461, U10  HD34216, U10 HD21397, U10 HD27904, U10 HD40492, U10  HD27856, U10 HD40521, U10 The relative risk of death in the hypothermia group as compared with the control group was 0.68 (95 percent confidence interval, 0.44 to 1.05; P=0.08). Data for all infants who did not die were censored; censoring is indicated by tick marks. In the hypothermia group, 19 infants died from the following causes during the initial hospitalization: asphyxial brain injury (12 infants), multiorgan failure (2), asphyxial brain injury and multiorgan failure (2), persistent pulmonary hypertension of the newborn (1), disseminated intravascular coagulopathy and asphyxial brain injury (1), and unknown (1). Five infants died from the following causes after hospital discharge: sudden infant death syndrome (1), respiratory failure or aspiration pneumonia (2), multiorgan failure (1), and unknown (1). In the control group, 29 infants died from the following causes during the initial hospitalization: asphyxial brain injury (22) , multiorgan failure (1), persistent pulmonary hypertension of the newborn (2), meconium aspiration syndrome (1), asphyxial brain injury and meconium aspiration syndrome (1), and sepsis (2) . Nine infants died from the following causes after hospital discharge: respiratory failure or aspiration pneumonia (5), multiorgan failure (1), and unknown (3). 
